The findings presented in this study elucidate the critical role of ROCK2 in the development of Pemigatinib resistance in CCA through the modulation of ferroptosis, particularly highlighting the involvement of the UBA52–Drp1 axis. This evidence concerns the gene UBA52 and cholangiocarcinoma.